John Rogers Ariel Investments
John W. Rogers Jr. is the founder of Ariel Investments, one of the best-known minority-owned investment firms in the United States. Ariel is associated with patient, value-oriented investing and a long-term “slow and steady” culture. Rogers is also a prominent voice on markets, corporate leadership, and inclusive capitalism.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Resideo Technologies
REZI
|
+$102M |
| 2 |
Boyd Gaming
BYD
|
+$93.3M |
| 3 |
Core Laboratories
CLB
|
+$92.4M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$75.4M |
| 5 |
Manchester United
MANU
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDP
Meredith Corporation
MDP
|
+$104M |
| 2 |
KKR & Co
KKR
|
+$41.3M |
| 3 |
Vail Resorts
MTN
|
+$38M |
| 4 |
First American
FAF
|
+$30.2M |
| 5 |
Baidu
BIDU
|
+$28.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.26% |
| 2 | Industrials | 17.88% |
| 3 | Communication Services | 16.05% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
AstraZeneca
AZN
$257B
| $1.44M | 0.01% |
12,370
-804
| -6% | -$94.6K |
|
102
Novartis
NVS
$302B
| $930K | 0.01% |
10,631
-7,905
| -43% | -$656K |
|
103
Sanofi
SNY
$110B
| $270K | ﹤0.01% |
5,385
-50
| -0.9% | -$2.47K |
|
104
M&T Bank
MTB
$34.7B
| $233K | ﹤0.01% |
+1,519
| New | +$233K |
|
105
MIND Technology
MIND
$41.2M
| – | – |
-82,786
| Closed | -$1.56M |
|
|
NVO
106
Novo Nordisk
NVO
$207B
| – | – |
-8,238
| Closed | -$395K |
|
107
Team
TISI
$104M
| – | – |
-32,626
| Closed | -$982K |
|
108
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
| – | – |
-39,240
| Closed | -$2.39M |
|
109
Vanguard Total World Stock ETF
VT
$81.1B
| – | – |
-19,064
| Closed | -$1.94M |
|
110
Weibo
WB
$1.73B
| – | – |
-118,792
| Closed | -$5.64M |
|
|
MDP
111
DELISTED
Meredith Corporation
MDP
| – | – |
-1,870,531
| Closed | -$104M |
|
Similar funds
John Rogers's Q4 2021 Portfolio in Review
As of Q4 2021, John Rogers held 111 positions worth $11.9B, up 8.5% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
John Rogers deployed $464M of net new capital in Q4 2021, opening 2 new positions and adding to 53 existing holdings. Its largest new stake was Lindblad Expeditions: 1,114,416 shares worth $17.4M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was KKR & Co, an estimated $41.3M trimmed.
- John Rogers's largest Q4 2021 buy was Lindblad Expeditions: 1,114,416 shares worth $17.4M.
- John Rogers added most to Resideo Technologies in Q4 2021, an estimated $102M increase.
- John Rogers's biggest Q4 2021 reduction was KKR & Co, cutting an estimated $41.3M.
- John Rogers fully exited Meredith Corporation in Q4 2021, selling an estimated $104M.
- John Rogers's ten largest holdings make up 31% of its $11.9B portfolio in Q4 2021.
- John Rogers opened 2 new positions and closed 7 in Q4 2021.
- John Rogers's portfolio value rose 8.5% quarter-over-quarter to $11.9B.
Based on Ariel Investments's 13F filing for Q4 2021, filed 14 Feb 2022.